title: FDA approval signals more 'homework' on the horizon in trials.
authors: Hannah
authors: H
authors: Waters
mesh_terms: D001559:Benzhydryl Compounds / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods; D003408:Cresols / Q000627:therapeutic use; D017277:Drug Approval / Q000379:methods* / Q000458:organization & administration; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D010665:Phenylpropanolamine / Q000627:therapeutic use; D012646:Self Administration / Q000379:methods; D000068737:Tolterodine Tartrate; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration; D053201:Urinary Bladder, Overactive / Q000188:drug therapy
chemical_list: D001559:Benzhydryl Compounds; D003408:Cresols; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate